STERIS plc (NYSE:STE) Shares Sold by Bank of America Corp DE

Bank of America Corp DE reduced its position in STERIS plc (NYSE:STE - Free Report) by 47.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 527,877 shares of the medical equipment provider's stock after selling 483,885 shares during the period. Bank of America Corp DE owned about 0.53% of STERIS worth $108,510,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Benjamin Edwards Inc. lifted its stake in shares of STERIS by 1.0% during the 4th quarter. Benjamin Edwards Inc. now owns 114,861 shares of the medical equipment provider's stock worth $23,614,000 after purchasing an additional 1,189 shares during the period. BNP Paribas Financial Markets raised its holdings in shares of STERIS by 44.8% during the 4th quarter. BNP Paribas Financial Markets now owns 163,280 shares of the medical equipment provider's stock valued at $33,564,000 after buying an additional 50,514 shares during the period. AXA S.A. lifted its position in STERIS by 526.1% during the 4th quarter. AXA S.A. now owns 19,628 shares of the medical equipment provider's stock worth $4,035,000 after acquiring an additional 16,493 shares in the last quarter. Gallagher Fiduciary Advisors LLC boosted its holdings in STERIS by 3.3% in the 4th quarter. Gallagher Fiduciary Advisors LLC now owns 1,970 shares of the medical equipment provider's stock worth $405,000 after acquiring an additional 63 shares during the period. Finally, Wahed Invest LLC raised its stake in shares of STERIS by 3.2% during the fourth quarter. Wahed Invest LLC now owns 2,469 shares of the medical equipment provider's stock valued at $508,000 after purchasing an additional 77 shares during the period. Institutional investors and hedge funds own 94.69% of the company's stock.

STERIS Stock Performance

Shares of STE stock opened at $226.54 on Friday. The stock has a market capitalization of $22.26 billion, a price-to-earnings ratio of 48.10 and a beta of 0.96. STERIS plc has a one year low of $200.98 and a one year high of $248.24. The company's 50-day simple moving average is $223.40 and its 200-day simple moving average is $218.85. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13.

STERIS (NYSE:STE - Get Free Report) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Shareholders of record on Tuesday, June 10th will be issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date of this dividend is Tuesday, June 10th. STERIS's dividend payout ratio is presently 48.41%.

Wall Street Analysts Forecast Growth

STE has been the subject of several analyst reports. Needham & Company LLC restated a "hold" rating on shares of STERIS in a research note on Monday, April 7th. Stephens upgraded STERIS to a "strong-buy" rating in a research note on Thursday, May 1st. Piper Sandler boosted their price target on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Finally, JMP Securities restated a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a research note on Thursday, April 10th. One research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.